Morocco to receive 2 million AstraZeneca Covid-19 vaccine doses on Friday

Henrietta Brewer
January 24, 2021

Last week, Canadian Health Minister Patty Hajdu said the country's national health department would make a decision on the AstraZeneca vaccine in the near future.

AstraZeneca has warned EU officials that the delivery of vaccines in the first quarter of this year will be delayed due to issues with European manufacturing.

.

He said AstraZeneca still expects to ship tens of millions of doses to the European Union in February and March as it ramps up production volumes.

AstraZeneca said in its statement that if European Union approval was granted, the "initial volumes will be lower than anticipated", although the start would not be delayed. He said Italian authorities were considering taking legal action against Pfizer, AP reported.


The vast majority of the production of the three most widely approved COVID vaccines, including the Astrazeneca drug, has so far been hoovered up by developed nations.

Irish Prime Minister Micheal Martin said of the delay. The company attributed the problems to the European supply chain.

Rabat has placed orders for 65 million doses, comprising 25 million of the AstraZeneca vaccine - for which it has deals with both Serum Institute of India (SII) and Russia's R-Pharm - and the remainder with China's Sinopharm.

"Now AstraZeneca puts a real problem in our midst, but we're gonna have to deal with it and see what else we can do", he added.


Some government officials however sought to reassure their countries - tired and battered by months of the pandemic and already on edge over slow vaccination rollouts.

The EU drug regulator is due to decide on approval of AstraZeneca's vaccine on January 29. The campaign for this batch of vaccine will be for people whom we have up until now not vaccinated, that is people above the age of 60.

The AstraZeneca vaccine has the advantage of being cheaper to produce and being simpler to store and transport than its rivals.

It has already received emergency authorisation in Britain. Many leaders expressed fury at Pfizer about an expected delay in deliveries of its vaccine, manufactured in partnership with BioNTech.


Sweden's national vaccination coordinator Richard Bergstrom said he expected his country to receive around 700,000 doses in the first month after the vaccine was authorised compared to one million expected initially. They will then evaluate the processes that can be employed for the rapid production of adjusted Covid-19 vaccines, if necessary.

Other reports by iNewsToday

FOLLOW OUR NEWSPAPER